QQQ   289.58 (-0.54%)
AAPL   137.35 (-2.46%)
MSFT   253.14 (-0.37%)
FB   191.29 (-0.49%)
GOOGL   2,207.68 (-1.35%)
AMZN   2,146.38 (+0.19%)
TSLA   709.42 (-0.05%)
NVDA   171.24 (+1.10%)
BABA   87.69 (+0.44%)
NIO   16.66 (+5.24%)
AMD   96.67 (+0.41%)
CGC   5.87 (+5.01%)
MU   69.40 (-2.32%)
T   20.21 (-0.10%)
GE   75.74 (+0.72%)
F   12.85 (+0.55%)
DIS   103.14 (-1.11%)
AMC   13.08 (+2.51%)
PFE   50.65 (+0.50%)
PYPL   81.28 (+5.31%)
NFLX   183.48 (+3.55%)
QQQ   289.58 (-0.54%)
AAPL   137.35 (-2.46%)
MSFT   253.14 (-0.37%)
FB   191.29 (-0.49%)
GOOGL   2,207.68 (-1.35%)
AMZN   2,146.38 (+0.19%)
TSLA   709.42 (-0.05%)
NVDA   171.24 (+1.10%)
BABA   87.69 (+0.44%)
NIO   16.66 (+5.24%)
AMD   96.67 (+0.41%)
CGC   5.87 (+5.01%)
MU   69.40 (-2.32%)
T   20.21 (-0.10%)
GE   75.74 (+0.72%)
F   12.85 (+0.55%)
DIS   103.14 (-1.11%)
AMC   13.08 (+2.51%)
PFE   50.65 (+0.50%)
PYPL   81.28 (+5.31%)
NFLX   183.48 (+3.55%)
QQQ   289.58 (-0.54%)
AAPL   137.35 (-2.46%)
MSFT   253.14 (-0.37%)
FB   191.29 (-0.49%)
GOOGL   2,207.68 (-1.35%)
AMZN   2,146.38 (+0.19%)
TSLA   709.42 (-0.05%)
NVDA   171.24 (+1.10%)
BABA   87.69 (+0.44%)
NIO   16.66 (+5.24%)
AMD   96.67 (+0.41%)
CGC   5.87 (+5.01%)
MU   69.40 (-2.32%)
T   20.21 (-0.10%)
GE   75.74 (+0.72%)
F   12.85 (+0.55%)
DIS   103.14 (-1.11%)
AMC   13.08 (+2.51%)
PFE   50.65 (+0.50%)
PYPL   81.28 (+5.31%)
NFLX   183.48 (+3.55%)
QQQ   289.58 (-0.54%)
AAPL   137.35 (-2.46%)
MSFT   253.14 (-0.37%)
FB   191.29 (-0.49%)
GOOGL   2,207.68 (-1.35%)
AMZN   2,146.38 (+0.19%)
TSLA   709.42 (-0.05%)
NVDA   171.24 (+1.10%)
BABA   87.69 (+0.44%)
NIO   16.66 (+5.24%)
AMD   96.67 (+0.41%)
CGC   5.87 (+5.01%)
MU   69.40 (-2.32%)
T   20.21 (-0.10%)
GE   75.74 (+0.72%)
F   12.85 (+0.55%)
DIS   103.14 (-1.11%)
AMC   13.08 (+2.51%)
PFE   50.65 (+0.50%)
PYPL   81.28 (+5.31%)
NFLX   183.48 (+3.55%)
NASDAQ:ADMA

ADMA Biologics SEC Filings & 10K Form

$2.05
+0.04 (+1.99%)
(As of 05/19/2022 12:00 AM ET)
Add
Compare
Today's Range
$1.98
$2.09
50-Day Range
$1.43
$2.12
52-Week Range
$1.01
$2.15
Volume
2.29 million shs
Average Volume
2.39 million shs
Market Capitalization
$401.64 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.07

ADMA Biologics (NASDAQ:ADMA) SEC Filings

DateFilerForm TypeView
05/13/2022
8:03 PM
ADMA Biologics (Issuer)
LENZ BRIAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2022
8:01 PM
ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2022
3:45 PM
ADMA Biologics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/28/2022
3:42 PM
ADMA Biologics (Filer)
Form DEFA14A
08/19/2021
6:58 PM
ADMA Biologics (Issuer)
EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/03/2021
11:15 PM
ADMA Biologics (Filer)
Form EFFECT
08/03/2021
8:05 AM
ADMA Biologics (Filer)
Form S-3/A
07/27/2021
6:00 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2021
4:00 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/28/2021
3:45 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/12/2021
4:10 PM
ADMA Biologics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/28/2021
8:41 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/07/2021
4:30 PM
ADMA Biologics (Filer)
Form DEF 14A
03/01/2021
8:04 PM
ADMA Biologics (Issuer)
DEMSKI MARTHA J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2021
8:04 PM
ADMA Biologics (Issuer)
Guiheen Lawrence P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2021
8:03 PM
ADMA Biologics (Issuer)
Fong Bryant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2021
8:03 PM
ADMA Biologics (Issuer)
Grossman Jerrold B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2021
8:02 PM
ADMA Biologics (Issuer)
ELMS STEVE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2021
8:02 PM
ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2021
8:01 PM
ADMA Biologics (Issuer)
Mond James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2021
8:01 PM
ADMA Biologics (Issuer)
LENZ BRIAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2021
2:37 PM
ADMA Biologics (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
Form SC 13G/A
02/16/2021
1:11 PM
ADMA Biologics (Subject)
Consonance Capital Management LP (Filed by)
Form SC 13G/A
02/03/2021
4:01 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/03/2021
4:01 PM
ADMA Biologics (Filer)
Form 424B5
02/01/2021
7:30 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/26/2021
7:31 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/19/2021
3:30 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2021
7:30 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/16/2020
3:46 PM
ADMA Biologics (Filer)
Form 8-A12B
12/16/2020
3:37 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/09/2020
7:15 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2020
4:20 PM
ADMA Biologics (Filer)
Form 424B5
11/05/2020
4:16 PM
ADMA Biologics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2020
3:37 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/14/2020
7:00 AM
ADMA Biologics (Issuer)
DEMSKI MARTHA J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2020
7:00 AM
ADMA Biologics (Issuer)
Grossman Jerrold B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2020
7:01 AM
ADMA Biologics (Issuer)
Mond James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2020
7:00 AM
ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2020
6:05 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/25/2020
7:00 AM
ADMA Biologics (Issuer)
Grossman Jerrold B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2020
7:00 AM
ADMA Biologics (Issuer)
DEMSKI MARTHA J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2020
7:01 AM
ADMA Biologics (Issuer)
Grossman Jerrold B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2020
7:02 AM
ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2020
7:02 AM
ADMA Biologics (Issuer)
LENZ BRIAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2020
7:01 AM
ADMA Biologics (Issuer)
Mond James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2020
4:23 PM
ADMA Biologics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/06/2020
7:01 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/18/2020
5:01 PM
ADMA Biologics (Issuer)
DEMSKI MARTHA J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2020
5:00 PM
ADMA Biologics (Issuer)
DEMSKI MARTHA J (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/18/2020
4:00 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/27/2020
7:00 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/21/2020
7:01 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2020
4:18 PM
ADMA Biologics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/28/2020
4:05 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/13/2020
4:02 PM
ADMA Biologics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/23/2020
7:30 AM
ADMA Biologics (Issuer)
EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2020
3:10 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/03/2020
6:12 PM
ADMA Biologics (Issuer)
Fong Bryant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2020
6:11 PM
ADMA Biologics (Issuer)
ELMS STEVE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2020
6:11 PM
ADMA Biologics (Issuer)
GOLDSTEIN DOV A MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2020
6:10 PM
ADMA Biologics (Issuer)
RICHMAN ERIC I (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2020
6:10 PM
ADMA Biologics (Issuer)
Guiheen Lawrence P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2020
6:09 PM
ADMA Biologics (Issuer)
Grossman Jerrold B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2020
6:08 PM
ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2020
6:08 PM
ADMA Biologics (Issuer)
LENZ BRIAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2020
6:07 PM
ADMA Biologics (Issuer)
Mond James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2020
6:30 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2020
11:17 AM
ADMA Biologics (Subject)
Consonance Capital Management LP (Filed by)
Form SC 13G/A
02/13/2020
4:27 PM
ADMA Biologics (Subject)
Broadfin Capital, LLC (Filed by)
Form SC 13G/A
02/11/2020
9:18 AM
ADMA Biologics (Issuer)
Guiheen Lawrence P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2020
9:16 AM
ADMA Biologics (Issuer)
Mond James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2020
9:15 AM
ADMA Biologics (Issuer)
Grossman Jerrold B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2020
9:13 AM
ADMA Biologics (Issuer)
LENZ BRIAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2020
9:11 AM
ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2020
7:02 AM
ADMA Biologics (Issuer)
EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2020
6:00 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/09/2020
6:30 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2020
6:30 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/17/2019
6:38 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/19/2019
4:18 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2019
6:18 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2019
4:29 PM
ADMA Biologics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2019
4:11 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2019
6:58 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/21/2019
6:58 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2019
6:49 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2019
11:15 PM
ADMA Biologics (Filer)
Form EFFECT
10/07/2019
3:11 PM
ADMA Biologics (Filer)
Form 424B7
10/07/2019
6:28 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2019
4:01 PM
ADMA Biologics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
10/03/2019
6:38 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2019
6:38 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/23/2019
6:38 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/23/2019
4:00 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/22/2019
7:08 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2019
6:29 AM
ADMA Biologics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2019
6:08 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/16/2019
3:48 PM
ADMA Biologics (Filer)
Form DEF 14A
07/08/2019
3:45 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
This page was last updated on 5/19/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.